Page last updated: 2024-10-21

hydroxyindoleacetic acid and Adenoma, beta-Cell

hydroxyindoleacetic acid has been researched along with Adenoma, beta-Cell in 2 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Toole, D1
Grossman, A1
Gross, D1
Delle Fave, G1
Barkmanova, J1
O'Connor, J1
Pape, UF1
Plöckinger, U1
Blanchin, M1
James-Deidier, A1
Chaumet-Riffaud, PD1
Chayvialle, JA1

Trials

1 trial available for hydroxyindoleacetic acid and Adenoma, beta-Cell

ArticleYear
[Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
    Presse medicale (Paris, France : 1983), 1992, Apr-18, Volume: 21, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Female; France; Gastrinoma; Glucagonoma; Humans; Hydroxyindoleacetic

1992

Other Studies

1 other study available for hydroxyindoleacetic acid and Adenoma, beta-Cell

ArticleYear
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
    Neuroendocrinology, 2009, Volume: 90, Issue:2

    Topics: Biomarkers; Chromogranin A; Fasting; Gastrinoma; Humans; Hydroxyindoleacetic Acid; Hypoglycemia; Ins

2009